MRK vs LLY

	MRK Merck & Co., Inc.	LLY ELI LILLY & Co
Price	$147.24	$1,306.69
Sector	Health Care	Health Care
X-Ray Score	33	62
Valuation	21	32
Growth	33	90
Profitability	44	62
Financial health	21	69
Dividends	56	63
Fair value	$115	$1,220
Verdict	Overvalued -22%	Fair -7%
Revenue (TTM)	$66.6B	$79.7B
Operating margin	11.6%	42.7%
Return on capital	6.1%	33.9%
Revenue growth (3y)	3.1%	31.7%
Free-cash-flow yield	4.4%	–
Net debt / EBITDA	6.1×	1.3×
Dividend yield	2.3%	0.5%

Scores and fair values are model estimates from SEC filings, ranked within each company's own sector, so scores of companies in different sectors are not directly comparable. Educational only, not financial advice.